THIRD AMENDMENT TO THE RESEARCH AD LICENSE AGREEMENTResearch Ad License Agreement • March 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research
Contract Type FiledMarch 16th, 2018 Company IndustryThis Third Amendment to Research and License Agreement (the “Third Amendment”) is made by and between The Technion Research & Development Foundation Ltd (“TRDF”) and Eloxx Pharmaceuticals Ltd. (“Licensee” or “Eloxx”).